PubMed

Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostone.

Shimazaki J, Hanada K, Yagi Y, Yamagami J, Ishioka M, Shimmura S, Tsubota K.

Br J Ophthalmol. 2000 Nov;84(11):1250-4.PMID: 11049949 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.

Nordmann JP, Rouland JF, Mertz BP.

Curr Med Res Opin. 1999;15(2):87-93.PMID: 10494491 [PubMed - indexed for MEDLINE]Related articles

Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.

Inoue K, Okugawa K, Kato S, Inoue Y, Tomita G, Oshika T, Amano S.

J Glaucoma. 2003 Dec;12(6):480-5.PMID: 14646683 [PubMed - indexed for MEDLINE]Related articles

A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.

Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, Kapik B, Shams N; Unoprostone Monotherapy Study Group-EU.

Am J Ophthalmol. 2002 Jan;133(1):1-10.PMID: 11755834 [PubMed - indexed for MEDLINE]Related articles

Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.

Manni G, Centofanti M, Oddone F, Parravano M, Bucci MG.

Am J Ophthalmol. 2005 Jan;139(1):72-7.PMID: 15652830 [PubMed - indexed for MEDLINE]Related articles

Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Day DG, Schacknow PN, Wand M, Sharpe ED, Stewart JA, Leech J, Stewart WC.

Am J Ophthalmol. 2003 Feb;135(2):138-43.PMID: 12566015 [PubMed - indexed for MEDLINE]Related articles

Clinical evaluation of UF-021 (Rescula; isopropyl unoprostone).

Yamamoto T, Kitazawa Y, Azuma I, Masuda K.

Surv Ophthalmol. 1997 Feb;41 Suppl 2:S99-103.PMID: 9154284 [PubMed - indexed for MEDLINE]Related articles

Adverse effects of topical antiglaucoma drugs on the ocular surface.

Arici MK, Arici DS, Topalkara A, Güler C.

Clin Experiment Ophthalmol. 2000 Apr;28(2):113-7.PMID: 10933774 [PubMed - indexed for MEDLINE]Related articles

[Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone]

Ohtake Y, Tanino T, Kimura I, Mashima Y, Oguchi Y.

Nippon Ganka Gakkai Zasshi. 2004 Jan;108(1):23-8. Japanese. PMID: 14969090 [PubMed - indexed for MEDLINE]Related articles

The efficacy of unoprostone isopropyl as an adjunct to topical beta-blocker in patients with open angle glaucoma: a-6-month study.

Leelachaikul Y, Euswas A.

J Med Assoc Thai. 2005 Nov;88 Suppl 9:S100-4.PMID: 16681060 [PubMed - indexed for MEDLINE]Related articles

Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface.

Ishibashi T, Yokoi N, Kinoshita S.

Cornea. 2003 Nov;22(8):709-15.PMID: 14576520 [PubMed - indexed for MEDLINE]Related articles

[The mechanism of corneal epithelial disorder induced by prostaglandin F2 alpha isopropyl unoprostone]

Toshino A, Okamoto S, Shimamura I, Miyamoto F, Hara Y, Kodama T, Ohashi Y.

Nippon Ganka Gakkai Zasshi. 1998 Feb;102(2):101-5. Japanese. PMID: 9513355 [PubMed - indexed for MEDLINE]Related articles

Effect of beta-blocker eyedrops on corneal epithelial barrier function.

Niiya A, Yokoi N, Matsumoto Y, Komuro A, Ishibashi T, Tomii S, He J, Kinoshita S.

Ophthalmologica. 2000 Sep-Oct;214(5):332-6.PMID: 10965246 [PubMed - indexed for MEDLINE]Related articles

The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.

Costagliola C, Parmeggiani F, Antinozzi PP, Caccavale A, Cotticelli L, Sebastiani A.

Exp Eye Res. 2005 Nov;81(5):610-5. Epub 2005 Jun 8.PMID: 15949795 [PubMed - indexed for MEDLINE]Related articles

Autologous serum eyedrops in the treatment of aniridic keratopathy.

López-García JS, Rivas L, García-Lozano I, Murube J.

Ophthalmology. 2008 Feb;115(2):262-7. Epub 2007 Aug 6.PMID: 17675158 [PubMed - indexed for MEDLINE]Related articles

Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

Orengo-Nania S, Landry T, Von Tress M, Silver LH, Weiner A, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Dec;132(6):860-8.PMID: 11730649 [PubMed - indexed for MEDLINE]Related articles

A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension.

Aung T, Chew PT, Yip CC, Chan YH, See JL, Khng CG, Hoh ST, Ng LH, Lee HM.

Am J Ophthalmol. 2001 May;131(5):636-42.PMID: 11336940 [PubMed - indexed for MEDLINE]Related articles

Ocular surface alteration after long-term treatment with an antiglaucomatous drug.

Herreras JM, Pastor JC, Calonge M, Asensio VM.

Ophthalmology. 1992 Jul;99(7):1082-8.PMID: 1495787 [PubMed - indexed for MEDLINE]Related articles

Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.

Michaud JE, Friren B; International Brinzolamide Adjunctive Study Group.

Am J Ophthalmol. 2001 Aug;132(2):235-43.PMID: 11476685 [PubMed - indexed for MEDLINE]Related articles

Effects of antiglaucoma drugs on ocular surface.

Yalvaç IS, Gedikoğlu G, Karagöz Y, Akgün U, Nurözler A, Koç F, Kasim R, Duman S.

Acta Ophthalmol Scand. 1995 Jun;73(3):246-8.PMID: 7493237 [PubMed - indexed for MEDLINE]Related articles